Caldera Medical acquires Ethicon's women's health product line

Caldera Medical, based in Los Angeles, has acquired Ethicon's Gynecare TVT product line. This acquisition marks a significant step for the company in its commitment to improve women's health. The TVT family includes several minimally invasive treatments for stress urinary incontinence, which affects many women. Caldera Medical plans to keep the same manufacturing facility and team for the TVT products. This should make the transition smooth for doctors and patients. The CEO of Caldera Medical emphasized that the quality and effectiveness of the TVT products will remain unchanged. Over the next few months, Caldera Medical will enhance customer support for the TVT products while also investing in care for more women. The company aims to strengthen its position as a leader in women's health. This acquisition follows Caldera Medical's recent purchases of Atlantic Therapeutics and UVision360, which added new non-invasive and hysteroscopy products to its offerings. These moves highlight Caldera Medical's focus on expanding access to advanced treatments for women. Caldera Medical has a strong reputation for developing medical devices that address various women's health issues, including stress urinary incontinence and pelvic organ prolapse. The company is also dedicated to providing care to underserved women, with a goal of reaching one million women by 2027 through its humanitarian program.